Differences in gray matter volumes of subcortical nuclei between major depressive disorder with and without persistent depressive disorder

被引:1
|
作者
Hung, Ching-, I [1 ,2 ]
Wu, Chen-Te [3 ]
Chao, Yi-Ping [4 ,5 ,6 ,7 ]
机构
[1] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan
[4] Chang Gung Univ, Grad Inst Biomed Engn, Taoyuan, Taiwan
[5] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp Linkou, Dept Neurol, Taoyuan, Taiwan
[7] Chang Gung Univ, Grad Inst Biomed Engn, Dept Comp Sci & Informat Engn, 259 Wenhua 1st Rd, Taoyuan 33302, Taiwan
关键词
Atrophy; Chronic depression; Dysthymia; Prognosis; 1ST EPISODE; FOLLOW-UP; PUTAMEN; METAANALYSIS; EDUCATION; SYMPTOMS; ATROPHY;
D O I
10.1016/j.jad.2022.10.021
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: This study aimed to compare the differences in gray matter volumes (GMVs) of subcortical nuclei between major depressive disorder (MDD) patients with and without persistent depressive disorder (PDD) at long-term follow-up. Methods: 114 and 94 subjects with MDD, including 48 and 41 with comorbid PDD, were enrolled to undergo high-resolution T1-weighted imaging at first (FIP) and second (three years later, SIP) investigation points, respectively. FreeSurfer was used to extract the GMVs of seven subcortical nuclei, and Generalized Estimating Equation models were employed to estimate the differences in GMVs of subcortical nuclei between the two subgroups. Results: The PDD subgroup had a significantly greater depressive severity and a higher percentage of patients undergoing pharmacotherapy at the FIP as compared with the non-PDD subgroup. These differences became insignificant at the SIP. The PDD subgroup had a significantly (p < 0.003) smaller GMV in the right putamen at the SIP and in the right nucleus accumbens (NAc) at the FIP and SIP as compared with the non-PDD subgroup. After controlling for clinical variables, PDD was independently associated with smaller GMVs in the right putamen and NAc. Limitations: Imaging was not performed at baseline and pharmacotherapy was not controlled at the FIP and SIP. Conclusions: MDD with PDD was associated with smaller GMVs in the right putamen and NAc as compared with MDD without PDD. Whether the two regions are biomarkers related to a poor prognosis and the chronicity of depression requires further study.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 50 条
  • [41] Irritability, Depressed Mood, Inattention and Spatial Working Memory in Children and Adolescents with Major Depressive Disorder With/Without Persistent Depressive Disorder
    Vance, Alasdair
    Winther, Jo
    CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2021, 52 (05) : 800 - 807
  • [42] Are youths with disruptive mood dysregulation disorder different from youths with major depressive disorder or persistent depressive disorder?
    Benarous, Xavier
    Renaud, Johanne
    Breton, Jean Jacques
    Cohen, David
    Labelle, Real
    Guile, Jean-Marc
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 265 : 207 - 215
  • [43] Clinical Comparison Between Adjustment Disorder with Depressive Mood and Major Depressive Disorder
    Temiz, Semiha Tufan
    Gulec, Gulcan
    Kaptanoglu, Cem
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (01): : 20 - 28
  • [44] Volumes of hippocampal subfields suggest a continuum between schizophrenia, major depressive disorder and bipolar disorder
    Cao, Peiyu
    Chen, Congxin
    Si, Qi
    Li, Yuting
    Ren, Fangfang
    Han, Chongyang
    Zhao, Jingjing
    Wang, Xiying
    Xu, Guoxin
    Sui, Yuxiu
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [45] Differences in the cluster of depressive symptoms between subjects with type 2 diabetes and individuals with a major depressive disorder and without diabetes
    J. Nicolau
    R. Simó
    C. Conchillo
    P. Sanchís
    J. Blanco
    J. M. Romerosa
    R. Fortuny
    A. Bonet
    L. Masmiquel
    Journal of Endocrinological Investigation, 2019, 42 : 881 - 888
  • [46] Pituitary gland volumes in major depressive disorder patients
    Eker, O. Donat
    Ovali, G. Yilmaz
    Eker, M. C.
    Kitis, O.
    Ozan, E.
    Akdeniz, F.
    Vahip, S.
    Gonul, A. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S292 - S292
  • [47] Differences in the cluster of depressive symptoms between subjects with type 2 diabetes and individuals with a major depressive disorder and without diabetes
    Nicolau, J.
    Simo, R.
    Conchillo, C.
    Sanchis, P.
    Blanco, J.
    Romerosa, J. M.
    Fortuny, R.
    Bonet, A.
    Masmiquel, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (08) : 881 - 888
  • [48] Discriminating Between Bipolar Disorder and Major Depressive Disorder
    Voehringer, Paul A.
    Perlis, Roy H.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2016, 39 (01) : 1 - +
  • [49] Volume changes of the subcortical limbic structures in major depressive disorder patients with and without anhedonia
    Mu, Qingli
    Cui, Dong
    Zhang, Kejing
    Ru, Yanghua
    Wu, Congchong
    Fang, Zhe
    Jia, Lili
    Hu, Shaohua
    Huang, Manli
    Lu, Shaojia
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2023, 336
  • [50] Altered gray matter volumes and plasma IL-6 level in major depressive disorder patients with suicidal ideation
    Guo, Yingrui
    Jiang, Xiaowei
    Jia, Linna
    Zhu, Yue
    Han, Xinyu
    Wu, Yifan
    Liu, Wen
    Zhao, Wenhui
    Zhu, Huaqian
    Wang, Dahai
    Tu, Zhaoyuan
    Zhou, Yifang
    Sun, Qikun
    Kong, Lingtao
    Wu, Feng
    Tang, Yanqing
    NEUROIMAGE-CLINICAL, 2023, 38